Ponasteroside A

Metabolite details

Identifier

CNAKQRUFJWYXIC-PPOCGGKUSA-N

InChI Key

CNAKQRUFJWYXIC-PPOCGGKUSA-N

IUPAC name

(2S,3R,5R,9R,10R,13R,14S,17S)-17-[(2R,3R)-2,3-dihydroxy-6-methylheptan-2-yl]-2,14-dihydroxy-10,13-dimethyl-3-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,3,4,5,9,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-6-one

Preferred name

Ponasteroside A

INN name

—

Synonym

—

ChEBI

CHEBI:176258

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Metabolic Dynamics of In Vitro CD8+ T Cell Activation.
• Diallyl disulfide (DADS) ameliorates intestinal Candida albicans infection by modulating the gut microbiota and metabolites and providing intestinal protection in mice
• Comparative Metabolomic Profiling of Compatible and Incompatible Interactions Between Potato and Phytophthora infestans
• Alterations in the gut microbiota and metabolomics of seafarers after a six-month sea voyage
• PatA mediates biofilm formation and drugs resistance through regulating the synthesis of glycolipids and lipids in mycobacterium PatA mediates a novel mycolic acid synthesis pathway and regulates biofilm formation in mycobacterium
• Disturbed Microbiota-Metabolites-Immune Interaction Network is Associated with Olfactory Dysfunction in Patients with Chronic Rhinosinusitis

Observed in differential profiles

• G3_Experimental_Sample_0h_vs_G11_Experimental_Sample_96h
• G1_PBS_vs_G2_DSS
• Ziyun_No.1_0h_vs_Ziyun_No.1_96h
• Control_0d_vs_Treatment_180d
• Control_0d_vs_Treatment_180d
• wild_type_vs_patA_deletion
• Normal_vs_Abnormal